Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

BioNJ

Life Sciences Talent Network Shaping Future Leaders in NJ’s Biotech Industry

Trenton, NJ, August 16, 2017Matt Alcalde, Director of Life Sciences Talent Network at BioNJ, writes:

Now in its second year, the Life Sciences Talent Advisory Board, managed by the Life Sciences Talent Network at BioNJ, has engaged over 100 employers from New Jersey’s robust health and life sciences industry.

These employers include pharmaceutical, biotechnology and medical device companies that are researching and developing new drugs and therapies to treat various diseases affecting patients worldwide as well as others who are supporting that work. Continue reading

Choose New Jersey Showcases State’s Assets, Resources at BIO International 2017 This Week

Princeton, NJ, June 22, 2017 — A delegation representing more than 20 New Jersey organizations, including top life sciences companies, universities, trade associations, State government and Choose New Jersey, Inc. is showcasing New Jersey’s assets and resources for biotechnology companies at the New Jersey Pavilion (Booth #1737) at BIO International 2017, June 19-22 (2017) in San Diego, California.

During the world’s largest biotechnology conference, members of the New Jersey delegation are holding business meetings with executives representing companies in North America, Europe and Asia interested in learning more about the benefits of a New Jersey location. Continue reading

BioNJ’s BioPartnering Conference Delivered a Day of Innovation, Partnering and Learning

Trenton, NJ, June 10, 2017BioNJ’s Seventh Annual BioPartnering Conference, in partnership with J.P. Morgan, took place on May 23 at the Busch Campus Center, Rutgers University in Piscataway.

The event brought together 300 regional biopharma executives, investors, academic liaisons and business development professionals from the region for a day of education, networking and collaboration.

“We couldn’t be happier with the outcome of last week’s event,” said BioNJ President and CEO Debbie Hart. Continue reading

Event: BioNJ to Partner with J.P. Morgan on 7th Annual BioPartnering Conference on May 23

Trenton, NJ, May 9, 2017 — In partnership with J.P. Morgan, BioNJ will host its Seventh Annual BioPartnering Conference on Tuesday, May 23, 2017, from 8:00 a.m. to 5:00 p.m. at the Busch Campus Center at Rutgers University in Piscataway.

The event is expected to bring together over 200 regional biopharmaceutical executives, investors, academic collaborators and business development professionals for a day of networking, 1-1 partnering meetings, company presentations, exhibits and plenary sessions.

“We’re thrilled to be partnering with J.P. Morgan on this year’s BioPartnering Conference,” said Debbie Hart, President and CEO, BioNJ. Continue reading

Governor Christie Signs Proclamation Announcing March as ‘New Jersey Life Sciences Month’

Trenton, NJ, April 9, 2017 — BioNJ announced that Governor Chris Christie had declared March 2017 as New Jersey Life Sciences Month.

Life Sciences Month was established to raise awareness of the robust medical innovation taking place in New Jersey and highlights the important impact that the industry has on New Jersey’s economy.

Click here to view Governor Christie’s signed Proclamation. Continue reading

Event: HINJ, BioNJ, NJ Rare Disease Alliance, NORD to Host ‘New Jersey Rare Disease Day 2017’ on February 27

New Brunswick, NJ, February 11, 2017 — New Jersey’s rare disease community will gather to celebrate Rare Disease Day 2017 on Monday, February 27 from 9:00 a.m. to 12:00 p.m. at the New Jersey Business and Industry Association (NJBIA) at 10 West Lafayette Street in Trenton.

The half-day event will be co-sponsored by BioNJ, the HealthCare Institute of New Jersey (HINJ), New Jersey Rare Disease Alliance and NORD.

The morning will begin at 9:00 a.m. with coffee, pastries and networking, followed by speakers from the rare disease community, including patients, patient advocates, legislators, biomedical healthcare professionals and life sciences community leaders. Continue reading

BioNJ Gala Speaker Predicts 21st Century ‘Cracking of Biology Nut’; Leaders Honored

Newark, NJ, February 3, 2017 — In what has become one of the top New Jersey life sciences events, the trade organization BioNJ last night held its 24th annual dinner meeting, networking event and innovation celebration at the Hilton East Brunswick, with some 650 people in attendance, reports George N. Saliba in New Jersey Business.

Rousing speeches by the likes of life sciences icon Fred Hassan, and, separately, journalist extraordinaire Joan Lunden, underscored the order-of-magnitude progress being made in the life sciences arena. Continue reading

Save the Date! ‘New Jersey Rare Disease Day 2017’ Set for February 27 in Trenton

Rare Disease DayTrenton, NJ, January 29, 2017 — New Jersey’s rare disease community will gather to celebrate Rare Disease Day 2017 on Monday, February 27 from 9:00 a.m. to 12:00 p.m. at the New Jersey Business and Industry Association (NJBIA) at 10 West Lafayette Street in Trenton.

The half-day event will be sponsored by BioNJ, the HealthCare Institute of New Jersey (HINJ), New Jersey Rare Disease Alliance and NORD.

The morning will begin at 9:00 a.m. with coffee, pastries and networking, followed by speakers from the rare disease community, including patients, patient advocates, legislators, biomedical healthcare professionals and life sciences community leaders. Continue reading

Event: BioNJ’s Gateway Gala to Salute Patients, Innovator Companies and Leadership on February 2

bionj-2017-galaTrenton, NJ, January 21, 2017BioNJ will present Innovator Awards honoring industry leaders, policy champions and Patient advocates who have reached significant milestones, as well as companies with a footprint in New Jersey that have received a drug approval in 2016 during its 24th Annual Gateway Gala and Innovation Celebration taking place February 2 at the Hilton East Brunswick.

The Gateway Gala will feature the presentation of the tenth Dr. Sol J. Barer Award for Vision, Innovation and Leadership to Fred Hassan, Partner and Managing Director, Warburg Pincus and Former Chairman of the Board & CEO, Schering-Plough.   Continue reading

Today! HINJ, BioNJ and NJ Tech Council Partner on NJEDA’s ‘Early Stage Biotech Investing in 2017’ Strategies Forum on January 17

Register Here SquareTrenton, NJ, January 17, 2017 — The HealthCare Institute of New Jersey (HINJ), BioNJ and the New Jersey Tech Council are partnering with the New Jersey Economic Development Authority (NJEDA) to present “Early Stage Biotech Investing in 2017: Strategies for a Changing Environment.”

The forum will be held on Tuesday, January 17 from 4:30 to 6:30 p.m. at the Commercialization Center for Innovative Technologies (CCIT), a life sciences incubator, at 675 US Highway One, North Brunswick, New Jersey.

The aim of the forum is to present an insightful conversation about how life sciences companies will be funded by venture capital firms in 2017.  Continue reading